GMS Contract for Culverhay Surgery

Tender description

NHS Gloucestershire ICB ("the ICB") held a General Medical Services (GMS) contract ("the Frampton Contract") with the Partners of Frampton Surgery (patient list size circa 5,275) for the provision of primary care services from Frampton Surgery, Frampton on Severn. The ICB also holds another GMS contract ("the Culverhay Contract") with the Partners of Culverhay Surgery (patient list size circa 12,160) for the provision of primary care services from Culverhay Surgery, Wotton-under-Edge. The Frampton Contract had become unviable as a standalone contract. The ICB therefore decided to terminate the Frampton Contract and incorporate the Frampton patient list into the Culverhay Contract by way of variation to the Culverhay Contract. The Frampton Surgery is now a branch surgery of the Culverhay Surgery. The Culverhay Contract is subject to the provisions of Chapter 3, Section 7 of the Public Contracts Regulations 2015 ("the PCR"). The ICB has relied on PCR 72(1)(b) and 72(1)(e) to effect a permitted variation to the Culverhay Contract to incorporate the Frampton Surgery as a branch surgery. The variation took effect on 1 January 2023. Lot 1: This section provides detail of the services covered by the Culverhay Contract and the variation of the Culverhay Contract. The Culverhay Contract is held between the ICB and the Partners of Culverhay Surgery, Wotton-under-Edge and covers the provision of primary care services to the patients registered with Culverhay Surgery. It is a GMS Contract that is subject to the requirements of the National Health Service (General Medical Services Contracts) Regulations 2015 (as amended). The Culverhay Contract has an indefinite term. A separate GMS contract for the provision of primary care services from the Frampton Surgery in Frampton on Severn recently became unviable as a standalone contract on the basis of, among other things, GP resourcing issues and costs. The Frampton partners therefore served notice to terminate the Frampton Contract and the ICB has transferred the Frampton patient list to the Culverhay Surgery by way of variation to the Culverhay Contract. The effect of the variation is to increase the number of patients managed under the Culverhay Contract from some 12,000 patients to some 17,000 patients. Funding paid by the ICB under the Culverhay Contract will therefore increase on an annual basis from £1,250,050 to £1,778,473. The value of the procurement listed in section II.1.7 is the value of the modification over four years.